CSIMarket
 

Ppd Inc   (NASDAQ: PPD)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Ppd Inc 's

Competitiveness




 

PPD Sales vs. its Competitors Q3 2021



Comparing the current results to its competitors, Ppd Inc reported Revenue increase in the 3 quarter 2021 by 26.5 % year on year.
The sales growth was above Ppd Inc 's competitors' average revenue growth of 26.06 %, achieved in the same quarter.

List of PPD Competitors

With a net margin of 10.84 % Ppd Inc achieved higher profitability than its competitors.

More on PPD Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Ppd Inc Net Income in the 3 quarter 2021 grew year on year by 1758%, faster than the Ppd Inc 's competitors average income growth of 278.57 %

<<  PPD Stock Performance Comparisons



  

Overall company Market Share Q3 2021

Due to strong revenue growth of 26.5 % in Overall company company increased its market share in this division.


<<  More on PPD Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Ppd Inc




Dlh Holdings Corp
Share Performance



-9.40%
30 Days



Dlh Holdings Corp
Profile

DLH Holdings Corp is a professional services company that provides solutions to the government and commercial clients. Their business model focuses on delivering highly-specialized healthcare services, engineering, and logistics support, helping their clients achieve their mission. DLH Holdings Corp operates through contracts and partnerships, leveraging their expertise to offer innovative solutions and drive operational efficiency for their clients.

More about Dlh Holdings Corp 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 63.552 mill. $ 253.542 mill. $ -21.566 mill.


Evotec Se
Share Performance



-40.25%
This Year



Evotec Se
Profile

Evotec SE is a German drug discovery and development company that operates on a contract research organization (CRO) business model. They offer a comprehensive range of services to pharmaceutical and biotechnology companies, including target identification and validation, hit identification, and lead optimization. Through collaborations and partnerships, Evotec aims to accelerate the discovery and development of new drugs and therapies.

More about Evotec Se's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 168.699 mill. $ 882.978 mill. $ -115.939 mill.


Medpace Holdings Inc
Share Performance



+21.91%
One Year



Medpace Holdings Inc
Profile

Medpace Holdings Inc is a contract research organization (CRO) that provides various services in the clinical research and development of drugs and medical devices.

More about Medpace Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 16,751.918 mill. $ 2,782.288 mill. $ 491.500 mill.


Quanterix Corporation
Share Performance



-59.72%
This Year



Quanterix Corporation
Profile

Quanterix Corp's business model is centered around developing and commercializing ultra-sensitive digital immunoassay platforms, which enable the detection and measurement of biomarkers with exceptional precision and accuracy.

More about Quanterix Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 122.163 mill. $ 152.716 mill. $ -123.108 mill.

Sources: Ppd Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Ppd Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.